Opioid agonist treatment, drug related deaths and dynamic models with Matt Hickman
Addiction Audio14 Elo 2022

Opioid agonist treatment, drug related deaths and dynamic models with Matt Hickman

In this episode, Professor Matt Hickman talks about using population modelling to identify the population implications of Opioid Agonist Treatment (OAT). He covers the impact that OAT has on drug-related deaths and other causes of mortality as well as how models can be used to explore what mortality rates would have been without OAT in New South Wales, Australia.


Professor Hickman talks about their findings that, without OAT, the number of overdose deaths would have been 50% higher.


“So, what we were trying to do in this study was to model the counter-factual of how many deaths there would be if there hadn’t been any opioid agonist treatment. In theory the ideal model would be a trial in which you have OAT versus no OAT in a population, now clearly that’s unethical and can’t be done.”


He also talks about how the research team set up a dynamic model that they used to explore the data, matching incarceration and OAT records. They then used those data alongside findings from systematic reviews to model the hypothetical impact of OAT on a real population.


“We’ve done models before, theoretical models which say ‘if we increase the opioid agonist treatment programme and we increase duration at a certain point what impact would that have?’ but that’s rarely based on actual real data. So …there’s modelling and there’s modelling, and this model is based on real empirical data and we think that gives it a bit more credence”.


Original paper here: Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia by Antoine Chaillon and colleagues. Published in Addiction (2022)

Hosted on Acast. See acast.com/privacy for more information.

Jaksot(112)

Retention in buprenorphine treatment with Albert Burgess-Hull

Retention in buprenorphine treatment with Albert Burgess-Hull

In this episode, Dr Elle Wadsworth talks to Dr Albert Burgess-Hull, the Scientific Director of SUDx and Head Data Scientist at MATClinics, US. The interview covers a short report examining treatment r...

24 Loka 202516min

What works for treating cannabis use disorder with Monika Halicka

What works for treating cannabis use disorder with Monika Halicka

In this episode, Dr Chloe Burke talks to Dr Monika Halicka, a Senior Research Associate at the Bristol Medical School, University of Bristol, UK. The interview covers a systematic review and meta-anal...

17 Loka 202513min

Genetic influence in addiction with Wei Deng

Genetic influence in addiction with Wei Deng

In this episode, Dr Tsen Vei Lim speaks to Dr Wei Deng, an assistant professor from McMaster University and St Joseph’s Healthcare Hamilton, Canada. The interview covers the research article Wei led e...

19 Syys 202519min

Nonmedical and medical ketamine use with Owen Bowden-Jones and Arun Sahai

Nonmedical and medical ketamine use with Owen Bowden-Jones and Arun Sahai

In this episode, Dr Elle Wadsworth speaks to Professor Owen Bowden-Jones from Central North-West London NHS Foundation and Mr Arun Sahai from Guy’s and St Thomas’ Hospitals NHS Trust, both in the UK. ...

5 Syys 202520min

Correcting misperceptions about vaping with Katie East

Correcting misperceptions about vaping with Katie East

In this episode, Dr Tsen Vei Lim talks to Dr Katie East, an Associate Professor in Public Health within the Department of Primary Care and Public Health at Brighton and Sussex Medical School in the UK...

29 Elo 202516min

Caregiver alcohol use and child maltreatment with June Leung

Caregiver alcohol use and child maltreatment with June Leung

In this episode, Dr Zoe Swithenbank speaks to Dr June Leung, a senior researcher at the SHORE and Whariki Research Centre at Massey University in New Zealand. The interview covers June’s systematic re...

22 Elo 202518min

Access to recreational cannabis in Switzerland with Lavinia Baltes

Access to recreational cannabis in Switzerland with Lavinia Baltes

In this episode, Dr Tsen Vei Lim talks to Dr Lavinia Baltes, Head of Research at the Clinic for Psychiatry and Psychotherapy, Psychiatric Services Aargau, Switzerland. The interview covers her researc...

8 Elo 202514min

Questionable generalisability of the AUDIT-C with Danilo Romero

Questionable generalisability of the AUDIT-C with Danilo Romero

In this episode, Dr Tsen Vei Lim talks to Dr Danilo Romero, a licensed clinical psychologist at the Stockholm Centre for Dependency Disorders in Sweden. The interview covers his research report on the...

1 Elo 202514min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
rss-lihavuudesta-podcast
rss-duodecim-lehti
utelias-mieli
tiedekulma-podcast
docemilia
rss-tervetta-skeptisyytta
mielipaivakirja
rss-ylistys-elaimille
koodikahvit
menologeja-tutkimusmatka-vaihdevuosiin
rss-ranskaa-raakana
rss-metsa
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita